Helicobacter hepaticus infection in mice: Models for understanding lower bowel inflammation and cancer

Mucosal Immunology

Volumn 4, Issue 1, 2011, Pages 22-30

  Fox, J G ^a   Ge, Z ^a   Whary, M T ^a   Erdman, S E ^a   Horwitz, B H ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; GAMMA INTERFERON; HYAB PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; KATA PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UREASE; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIUM ISOLATION; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; COLITIS; COLORECTAL CANCER; ENTERITIS; FLAGELLAR GENE; HELICOBACTER BILIS; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HEPATITIS; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE POLYP; LARGE INTESTINE CANCER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 78650828652     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.61     Document Type: Review

References (97)

1. Fox, J. G. et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32, 1238-1245 (1994).
2. Ward, J. M. et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J. Natl Cancer. Inst. 86, 1222-1227 (1994).
3. Fox, J. G. et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: A model of Helicobacter-induced carcinogenesis. Infect. Immun. 64, 1548-1558 (1996).
4. Boutin, S. R. et al. Helicobacter pullorum outbreak in C57BL/6NTac and C3H/HeNTac barrier-maintained mice. J. Clin. Microbiol. 48, 1908-1910 (2010).
5. Shames, B. et al. Identifi cation of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33, 2968-2972 (1995).
6. Taylor, N. S., Xu, S., Nambiar, P., Dewhirst, F. E. & Fox, J. G. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J. Clin. Microbiol. 45, 2166-2172 (2007).
7. Berg, D. J. et al. Enterocolitis and colon cancer in interleukin-10-defi cient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98, 1010-1020 (1996).
8. Ward, J. M. et al. Infl ammatory large bowel disease in immunodefi cient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46, 15-20 (1996).
9. Foltz, C. J. et al. Spontaneous infl ammatory bowel disease in multiple mutant mouse lines: Association with colonization by Helicobacter hepaticus. Helicobacter 3, 69-78 (1998).
10. Cahill, R. J. et al. Infl ammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 65, 3126-3131 (1997).
11. Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. & Coffman, R. L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal infl ammation in C. B-17 scid mice. Int. Immunol. 5, 1461-1471 (1993).
12. Powrie, F. et al. Inhibition of Th1 responses prevents infl ammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553-562 (1994).
13. Kullberg, M. C. et al. Helicobacter hepaticus triggers colitis in specifi cpathogen- free interleukin-10 (IL-10)-defi cient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66, 5157-5166 (1998).
14. Burich, A. et al. Helicobacter-induced infl ammatory bowel disease in IL-10- and T cell-defi cient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G764-778 (2001).
15. Erdman, S. E., Poutahidis, T., Rogers, A. B., Tomszaki, M., Horwitz, B. & Fox, J. G. Susceptibility of three strains of Rag2-defi cient mice to Helicobacter hepaticus induced colitis and colorectal cancer. Gastroenterology 124 (Suppl 1), A340 (2003).
16. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin- 10-defi cient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
17. Dieleman, L. A. et al. Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-defi cient mice. Infect. Immun. 68, 5107-5113 (2000).
18. Kullberg, M. C. et al. Helicobacter hepaticus -induced colitis in interleukin- 10-defi cient mice: Cytokine requirements for the induction and maintenance of intestinal infl ammation. Infect. Immun. 69, 4232-4241 (2001).
19. Kullberg, M. C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203, 2485-2494 (2006).
20. Leppkes, M. et al. ROR gamma-expressing Th17 cells induce murine chronic intestinal infl ammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257-267 (2009).
21. O'Connor, W. Jr et al. A protective function for interleukin 17A in T cell-mediated intestinal infl ammation. Nat. Immunol. 1, 603-609 (2009).
22. Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from infl ammatory bowel disease. Immunity 29, 947-957 (2008).
23. Sugimoto, K. et al. IL-22 ameliorates intestinal infl ammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
24. Erdman, S. E. et al. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63, 6042-6050 (2003).
25. Maloy, K. J. et al. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
26. Tomczak, M. F. et al. NF-kappa B is required within the innate immune system to inhibit microfl ora-induced colitis and expression of IL-12 p40. J. Immunol. 171, 1484-1492 (2003).
27. von Freeden-Jeffry, U. et al. IL-7 defi ciency prevents development of a non- T cell non-B cell-mediated colitis. J. Immunol. 161, 5673-5680 (1998).
28. Erdman, S. E. et al. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-defi cient mice. Am. J. Pathol. 162, 691-702 (2003).
29. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal infl ammation. J. Exp. Med. 203, 2473-2483 (2006).
30. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
31. Eberl, G. & Littman, D. R. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305, 248-251 (2004).
32. Eberl, G. et al. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73 (2004).
33. Ivanov, I.I. et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinfl ammatory IL-17+ T helper cells. Cell 126, 1121-1133 (2006).
34. Adachi, S. et al. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10, 1-6 (1998).
35. Maloy, K. J., Antonelli, L. R., Lefevre, M. & Powrie, F. Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol. Lett. 97, 189-192 (2005).
36. Kullberg, M. C. et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus -induced colitis. J. Exp. Med. 196, 505-515 (2002).
37. Poutahidis, T. et al. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis 28, 2614-2623 (2007).
38. Tomczak, M. F. et al. Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus. J. Immunol. 176, 1244-1251 (2006).
39. Wang, Y. et al. c-Rel is essential for the development of innate and T cellinduced colitis. J. Immunol. 180, 8118-8125 (2008).
40. Tomczak, M. F. et al. Inhibition of Helicobacter hepaticus -induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. J. Immunol. 177, 7332-7339 (2006).
41. Mandell, L. et al. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via tolllike receptor 2 but not toll-like receptor 4. Infect. Immun. 72, 6446-6454 (2004).
42. Boulard, O., Asquith, M. J., Powrie, F. & Maloy, K. J. TLR2-independent induction and regulation of chronic intestinal infl ammation. Eur. J. Immunol. 40, 516-524 (2009).
43. Asquith, M. J., Boulard, O., Powrie, F. & Maloy, K. J. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of infl ammatory bowel disease. Gastroenterology 139, 519-529 (2010).
44. Fritz, J. H., Ferrero, R. L., Philpott, D. J. & Girardin, S. E. Nod-like proteins in immunity, infl ammation and disease. Nat. Immunol. 7, 1250-1257 (2006).
45. Chow, J. & Mazmanian, S. K. A pathobiont of the microbiota balances host colonization and intestinal infl ammation. Cell Host Microbe 7, 265-276 (2010).
46. Chaouche-Drider, N. et al. A commensal Helicobacter sp. of the rodent intestinal fl ora activates TLR2 and NOD1 responses in epithelial cells. PLoS One 4, e5396 (2009).
47. Sterzenbach, T. et al. Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells. Infect. Immun. 75, 2717-2728 (2007).
48. Petnicki-Ocwieja, T. et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl Acad. Sci. USA 106, 15813-15818 (2009).
49. Garcia, A. et al. Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus -infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks. Infect. Immun. 76, 1866-1876 (2008).
50. Ihrig, M., Schrenzel, M. D. & Fox, J. G. Differential susceptibility to hepatic infl ammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am. J. Pathol. 155, 571-582 (1999).
51. Ward, J. M., Anver, M. R., Haines, D. C. & Benveniste, R. E. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am. J. Pathol. 145, 959-968 (1994).
52. Fox, J. G. et al. Gut microbes defi ne liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 59, 88-97 (2010).
53. Engle, S. J. et al. Elimination of colon cancer in germ-free transforming growth factor beta 1-defi cient mice. Cancer Res. 62, 6362-6366 (2002).
54. Boivin, G. P. et al. Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 124, 762-777 (2003).
55. Riddell, R. H. et al. Dysplasia in infl ammatory bowel disease: Standardized classifi cation with provisional clinical applications. Hum. Pathol. 14, 931-968 (1983).
56. Erdman, S. E. et al. Nitric oxide and TNF-alpha trigger colonic infl ammation and carcinogenesis in Helicobacter hepaticus -infected, Rag2-defi cient mice. Proc. Natl Acad. Sci. USA 106, 1027-1032 (2009).
57. Rao, V. P. et al. Innate immune infl ammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 66, 7395-7400 (2006).
58. Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324 (1990).
59. Erdman, S. E. et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res. 65, 3998-4004 (2005).
60. Rao, V. P. et al. Proinfl ammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc (Min/+) mice. Cancer Res. 66, 57-61 (2006).
61. Newman, J. V., Kosaka, T., Sheppard, B. J., Fox, J. G. & Schauer, D. B. Bacterial infection promotes colon tumorigenesis in Apc (Min/+) mice. J. Infect. Dis. 184, 227-230 (2001).
62. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17T cell responses. Nat. Med. 15, 1016-1022 (2009).
63. Erdman, S. E. et al. Unifying roles for regulatory T cells and infl ammation in cancer. Int. J. Cancer 126, 1651-1665 (2010).
64. Rao, V. P., Poutahidis, T., Fox, J. G. & Erdman, S. E. Breast cancer: Should gastrointestinal bacteria be on our radar screen? Cancer Res. 67, 847-850 (2007).
65. Suerbaum, S. et al. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc. Natl Acad. Sci. USA 100, 7901-7906 (2003).
66. Smith, J. L. & Bayles, D. O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 32, 227-248 (2006).
67. Ge, Z., Schauer, D. B. & Fox, J. G. In vivo virulence properties of bacterial cytolethal-distending toxin. Cell Microbiol. 10, 1599-1607 (2008).
68. Chien, C. C. et al. Identifi cation of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J. Med. Microbiol. 49, 525-534 (2000).
69. Taylor, N. S., Ge, Z., Shen, Z., Dewhirst, F. E. & Fox, J. G. Cytolethal distending toxin: A potential virulence factor for Helicobacter cinaedi. J. Infect. Dis. 188, 1892-1897 (2003).
70. Young, V. B. et al. Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J. Infect. Dis. 182, 620-623 (2000).
71. Ge, Z. et al. Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice. Infect. Immun. 73, 3559-3567 (2005).
72. Pratt, J. S., Sachen, K. L., Wood, H. D., Eaton, K. A. & Young, V. B. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect. Immun. 74, 4496-4504 (2006).
73. Young, V. B. et al. In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants. Infect. Immun. 72, 2521-2527 (2004).
74. Shen, Z. et al. Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-defi cient mice. Infect. Immun. 77, 2508-2516 (2009).
75. Guerra, L. et al. Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS One 5, e8924 (2010).
76. Liyanage, N. P. et al. Helicobacter hepaticus cytolethal distending toxin causes cell death in intestinal epithelial cells via mitochondrial apoptotic pathway. Helicobacter 15, 98-107 (2010).
77. Gal-Mor, O. & Finlay, B. B. Pathogenicity islands: A molecular toolbox for bacterial virulence. Cell Microbiol. 8, 1707-1719 (2006).
78. Boutin, S. R. et al. Different Helicobacter hepaticus strains with variable genomic content induce various degrees of hepatitis. Infect. Immun. 73, 8449-8452 (2005).
79. Ge, Z. et al. Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129- IL10 tm1Cgn mice. Microbes. Infect. 10, 726-733 (2008).
80. Burne, R. A. & Chen, Y. Y. Bacterial ureases in infectious diseases. Microbes Infect. 2, 533-542 (2000).
81. Ge, Z. et al. Helicobacter hepaticus urease is not required for intestinal colonization but promotes hepatic infl ammation in male A/JCr mice. Microb. Pathog. 45, 18-24 (2008).
82. Belzer, C. et al. Differential regulation of urease activity in Helicobacter hepaticus and Helicobacter pylori. Microbiology 151, 3989-3995 (2005).
83. Belzer, C., van Schendel, B. A., Kuipers, E. J., Kusters, J. G. & van Vliet, A. H. Iron-responsive repression of urease expression in Helicobacter hepaticus is mediated by the transcriptional regulator Fur. Infect. Immun. 75, 745-752 (2007).
84. Alyamani, E. J. et al. Helicobacter hepaticus catalase shares surfacepredicted epitopes with mammalian catalases. Microbiology 153, 1006-1016 (2007).
85. Hong, Y., Wang, G. & Maier, R. J. A Helicobacter hepaticus catalase mutant is hypersensitive to oxidative stress and suffers increased DNA damage. J. Med. Microbiol. 56, 557-562 (2007).
86. Mehta, N. S., Benoit, S., Mysore, J. V., Sousa, R. S. & Maier, R. J. Helicobacter hepaticus hydrogenase mutants are defi cient in hydrogen-supported amino acid uptake and in causing liver lesions in A/J mice. Infect. Immun. 73, 5311-5318 (2005).
87. Sterzenbach, T. et al. Role of the Helicobacter hepaticus fl agellar sigma factor FliA in gene regulation and murine colonization. J. Bacteriol. 190, 6398-6408 (2008).
88. Chin, E. Y., Dangler, C. A., Fox, J. G. & Schauer, D. B. Helicobacter hepaticus infection triggers infl ammatory bowel disease in T cell receptor alpha\beta mutant mice. Comp. Med. 50, 586-594 (2000).
89. Shomer, N. H., Dangler, C. A., Schrenzel, M. D. & Fox, J. G. Helicobacter bilis- induced infl ammatory bowel disease in scid mice with defi ned fl ora. Infect. Immun. 65, 4858-4864 (1997).
90. Shomer, N. H., Dangler, C. A., Marini, R. P. & Fox, J. G. Helicobacter bilis / Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice. Lab. Anim. Sci. 48, 455-459 (1998).
91. Fox, J. G. et al. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64, 3673-3681 (1996).
92. Erdman, S., Fox, J. G., Dangler, C. A., Feldman, D. & Horwitz, B. H. Typhlocolitis in NF-kappa B-defi cient mice. J. Immunol. 166, 1443-1447 (2001).
93. Maggio-Price, L. et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-defi cient (mdr1a-/ -) mice. Am. J. Pathol. 160, 739-751 (2002).
94. Maggio-Price, L. et al. Helicobacter infection is required for infl ammation and colon cancer in SMAD3-defi cient mice. Cancer Res. 66, 828-838 (2006).
95. Fox, J. G. et al. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-defi cient mice. Infect. Immun. 67, 1757-1762 (1999).
96. Franklin, C. L. et al. Helicobacter typhlonius sp. nov., a novel murine urease-negative Helicobacter species. J. Clin. Microbiol. 39, 3920-3926 (2001).
97. Whary, M. T. et al. Rapid onset of ulcerative typhlocolitis in B6. 129P2- IL10 tm1Cgn (IL-10-/ -) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler β s fl ora. Infect. Immun. 74, 6615-6623 (2006).